Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19

Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19

Coronaviruses are non-segmented and single stranded positive-sense RNA (+ssRNA) viruses. To date, 06 human coronaviruses (HCoVs) are reported; α-CoVs (HCoVs-NL63 and HCoVs-229E) and β-CoVs (HCoVs-OC43, HCoVs-HKU1, SARS-CoV, MERS-CoV). While, novel coronavirus (SARS-CoV-2) is the most recent member....

Full description

Bibliographic Details
Main Authors:	Faheem Hyder Pottoo, Tareq Abu-Izneid, Abdallah Mohammad Ibrahim, Md. Noushad Javed, Noora AlHajri, Amar M. Hamrouni
Format:	Article
Language:	English
Published:	Elsevier 2021-02-01
Series:	Saudi Pharmaceutical Journal
Subjects:	Acute respiratory distress syndrome (ARDS) SARS-CoV MERS-CoV SARS-CoV-2 COVID-19 Cytokine storm
Online Access:	http://www.sciencedirect.com/science/article/pii/S1319016421000049

Similar Items

In Silico Design of Peptide-Based SARS-CoV-2 Fusion Inhibitors That Target WT and Mutant Versions of SARS-CoV-2 HR1 Domains
by: Shana V. Stoddard, et al.
Published: (2021-07-01)

Chemokine Regulation During Epidemic Coronavirus Infection
by: Shamik Majumdar, et al.
Published: (2021-02-01)

Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects
by: Przemyslaw Wielgat, et al.
Published: (2020-08-01)

Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
by: Ridhima Kaul, et al.
Published: (2021-10-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

Comment on Alfassam et al. Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles. <i>Pharmaceutics</i> 2021, <i>13</i>, 502
by: Milad Zandi, et al.
Published: (2022-09-01)

Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach
by: Taimoor Khan, et al.
Published: (2022-04-01)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
by: Sicong Yu, et al.
Published: (2021-06-01)

Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight
by: Chunting He, et al.
Published: (2020-07-01)

EMERGENCIA DE SARS-COV-2. ASPECTOS BÁSICOS SOBRE SU ORIGEN, EPIDEMIOLOGÍA, ESTRUCTURA Y PATOGENIA PARA CLÍNICOS
by: Jeannette Dabanch
Published: (2021-01-01)

Recent Chronology of COVID-19 Pandemic
by: Sazada Siddiqui, et al.
Published: (2022-05-01)

The interplay between emerging human coronavirus infections and autophagy
by: Zhenyu Zhao, et al.
Published: (2021-01-01)

Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
by: Jung Eun Huh, et al.
Published: (2021-04-01)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
by: Yun-yu Zhang, et al.
Published: (2020-08-01)

Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01)

Insight into 2019 novel coronavirus — An updated interim review and lessons from SARS-CoV and MERS-CoV
by: Mingxuan Xie, et al.
Published: (2020-05-01)

Comparative transcriptome analysis of SARS-CoV-2, SARS-CoV, MERS-CoV, and HCoV-229E identifying potential IFN/ISGs targets for inhibiting virus replication
by: Yuzhuang Liu, et al.
Published: (2023-12-01)

Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections
by: Ashutosh Khaswal, et al.
Published: (2022-07-01)

SARS, MERS and COVID-19-Associated Renal Pathology
by: Hristo Popov, et al.
Published: (2022-10-01)

<i>Betacoronavirus</i> Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic
by: Alejandro Llanes, et al.
Published: (2020-06-01)

An Overview of the Pathogenesis, Transmission, Diagnosis, and Management of Endemic Human Coronaviruses: A Reflection on the Past and Present Episodes and Possible Future Outbreaks
by: Adeoye J. Kayode, et al.
Published: (2021-08-01)

Immune Profiling of COVID-19 in Correlation with SARS and MERS
by: Bariaa A. Khalil, et al.
Published: (2022-01-01)

Honokiol Inhibits SARS-CoV-2 Replication in Cell Culture at a Post-Entry Step
by: Clarisse Salgado-Benvindo, et al.
Published: (2023-06-01)

Contribution to pathogenesis of accessory proteins of deadly human coronaviruses
by: Jesus Hurtado-Tamayo, et al.
Published: (2023-05-01)

POTENTIAL RISK OF BRAIN DAMAGE AND POOR DEVELOPMENTAL OUTCOMES IN CHILDREN PRENATALLY EXPOSED TO SARS-COV-2: A SYSTEMATIC REVIEW
by: Marcio Leyser, et al.
Published: (2021-05-01)

The biological diversity of coronaviruses: where will the new threat come from?
by: Alexandr Khaitovich, et al.
Published: (2022-05-01)

Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives
by: Balasubramanian Ganesh, et al.
Published: (2021-04-01)

Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence
by: Jacques L. Tamuzi, et al.
Published: (2020-10-01)

Susceptibility to SARS-CoV-2 and MERS-CoV in Beagle Dogs
by: Kwang-Soo Lyoo, et al.
Published: (2023-02-01)

The relation between avian coronaviruses and SARS-CoV-2 coronavirus
by: Hanan Al-Khalaifah, et al.
Published: (2022-10-01)

Toward Understanding Molecular Bases for Biological Diversification of Human Coronaviruses: Present Status and Future Perspectives
by: Takaaki Koma, et al.
Published: (2020-08-01)

Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses
by: Nicola Borbone, et al.
Published: (2021-02-01)

Development of Coronavirus Treatments Using Neutralizing Antibodies
by: Saman Fouladirad, et al.
Published: (2021-01-01)

Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds
by: Philip L. Tzou, et al.
Published: (2020-09-01)

Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)
by: Francesco Sessa, et al.
Published: (2021-03-01)

A SARS-CoV-2: Companion Animal Transmission and Variants Classification
by: Rachana Pandit, et al.
Published: (2023-05-01)

Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
by: Ujjwal Neogi, et al.
Published: (2020-04-01)

Evolutionary Dynamics and Epidemiology of Endemic and Emerging Coronaviruses in Humans, Domestic Animals, and Wildlife
by: Ariful Islam, et al.
Published: (2021-09-01)

Bioactive natural compounds against human coronaviruses: a review and perspective
by: Yanfang Xian, et al.
Published: (2020-07-01)

From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses
by: Zhixing Zhu, et al.
Published: (2020-08-01)